DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease
Ghada Mkannez(Université Laval), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 40
Related Papers
A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
|npj Genomic Medicine|2019|174
Innate and Adaptive Immunity in Calcific Aortic Valve Disease
|Journal of Immunology Research|2015|115
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-κB pathway
|Cardiovascular Research|2017|94
Increased Biglycan in Aortic Valve Stenosis Leads to the Overexpression of Phospholipid Transfer Protein via Toll-Like Receptor 2
|American Journal Of Pathology|2010|71